Zhong Anny, Augello Patrick, Asbell Penny, Ying Gui-Shuang
Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA.
Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA.
Cornea. 2025 Feb 1;44(2):149-156. doi: 10.1097/ICO.0000000000003605. Epub 2024 Jul 30.
To investigate intereye agreement in dry-eye disease (DED) signs in the Dry Eye Assessment and Management study.
Tear break-up time (TBUT), Schirmer test, conjunctival staining, corneal staining, meibomian gland dysfunction (MGD), and tear osmolarity were measured at baseline, 3, 6, and 12 months. Intereye agreement was assessed by intraclass correlation coefficient, weighted kappa, and percentage of participants with absolute intereye difference (AID) exceeding a clinically significant threshold (2 points for conjunctival staining and MGD, 2 seconds for TBUT, 3 points for corneal staining, 5 mm/5 minutes for Schirmer test, and 8 mOsms/L for osmolarity). The worse eye at each visit for each DED sign was determined as the eye with a sign worse than the contralateral eye by at least the clinically significant threshold.
DED signs had moderate-to-good intereye agreement with intraclass correlation coefficient ranging from 0.45 (tear osmolarity) to 0.81 (corneal staining and Schirmer test) and weighted kappa from 0.58 (plugging) to 0.69 (lid secretion). Percentage of participants exceeding threshold AID was 15% to 20% for conjunctival staining, 11% to 15% for TBUT, 17% to 21% for MGD, 13% to 18% for corneal staining, 21% to 23% for Schirmer test, and 44% to 47% for osmolarity. The eye with a worse DED sign ranged between 36% (TBUT) and 80% (osmolarity) of participants.
Participants demonstrated moderate-to-good intereye agreement, yet a substantial portion showed clinically significant intereye differences in each sign. The worse eye was not the same eye in the majority during follow-up. These findings suggest considering signs from both eyes in future DED trials.
在干眼评估与管理研究中调查干眼疾病(DED)体征的双眼一致性。
在基线、3个月、6个月和12个月时测量泪膜破裂时间(TBUT)、泪液分泌试验、结膜染色、角膜染色、睑板腺功能障碍(MGD)和泪液渗透压。通过组内相关系数、加权kappa以及双眼绝对差值(AID)超过临床显著阈值的参与者百分比(结膜染色和MGD为2分,TBUT为2秒,角膜染色为3分,泪液分泌试验为5 mm/5分钟,渗透压为8 mOsms/L)评估双眼一致性。每次访视时,将每个DED体征较差的眼确定为该体征比对侧眼至少差临床显著阈值的眼。
DED体征具有中度至良好的双眼一致性,组内相关系数范围为0.45(泪液渗透压)至0.81(角膜染色和泪液分泌试验),加权kappa范围为0.58(堵塞)至0.69(睑部分泌物)。结膜染色超过阈值AID的参与者百分比为15%至20%,TBUT为11%至15%,MGD为17%至21%,角膜染色为13%至18%,泪液分泌试验为21%至23%,渗透压为44%至47%。DED体征较差的眼在参与者中所占比例在36%(TBUT)至80%(渗透压)之间。
参与者表现出中度至良好的双眼一致性,但相当一部分人在每个体征上都存在具有临床意义的双眼差异。在随访期间,大多数情况下较差的眼并非同一只眼。这些发现提示在未来的DED试验中应考虑双眼的体征。